​
​

Evoke Pharma (EVOK) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Evoke Pharma Revenue Highlights

Latest Revenue (Y)

$5.18M

Latest Revenue (Q)

$2.65M

Evoke Pharma Revenue by Period

Evoke Pharma Revenue by Year

DateRevenueChange
2023-12-31$5.18M106.51%
2022-12-31$2.51M55.04%
2021-12-31$1.62M6929.00%
2020-12-31$23.02K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Evoke Pharma generated $5.18M in revenue during NA 2023, up 106.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Evoke Pharma Revenue by Quarter

DateRevenueChange
2024-09-30$2.65M4.03%
2024-06-30$2.55M47.01%
2024-03-31$1.74M3.55%
2023-12-31$1.68M7.24%
2023-09-30$1.56M38.14%
2023-06-30$1.13M39.60%
2023-03-31$810.41K1.76%
2022-12-31$796.37K-4.29%
2022-09-30$832.10K80.19%
2022-06-30$461.80K10.38%
2022-03-31$418.38K16.03%
2021-12-31$360.57K-61.25%
2021-09-30$930.45K293.20%
2021-06-30$236.63K161.70%
2021-03-31$90.42K292.79%
2020-12-31$23.02K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31--

Evoke Pharma generated $2.65M in revenue during Q3 2024, up 4.03% compared to the previous quarter, and up 234.60% compared to the same period a year ago.

Evoke Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
PROCProcaps Group$409.92M$118.41M
EGRXEagle Pharmaceuticals$316.61M$64.65M
DERMJourney Medical$79.18M$14.86M
AQSTAquestive Therapeutics$50.58M$13.54M
CPIXCumberland Pharmaceuticals$39.55M$9.09M
BFRIBiofrontera$34.01M$7.83M
AVDLAvadel Pharmaceuticals$27.96M$50.02M
AGRXAgile Therapeutics$19.59M$5.58M
GHSIGuardion Health Sciences$12.25M$36.35K
JUPWSafety Shot$6.20M$910.01K
EVOKEvoke Pharma$5.18M$2.65M
ADMPAdamis Pharmaceuticals$4.76M$9.06M
AKANAkanda$2.16M$762.61K
ACRXTalphera$651.00K$117.00K
SHPHShuttle Pharmaceuticals--
IXHLIncannex Healthcare-$12.00K
PRFXPainReform--
RGCRegencell Bioscience--

EVOK Revenue FAQ

What is Evoke Pharma’s yearly revenue?

Evoke Pharma's yearly revenue for 2023 was $5.18M, representing an increase of 106.51% compared to 2022. The company's yearly revenue for 2022 was $2.51M, representing an increase of 55.04% compared to 2021. EVOK's yearly revenue for 2021 was $1.62M, representing an increase of 6929.00% compared to 2020.

What is Evoke Pharma’s quarterly revenue?

Evoke Pharma's quarterly revenue for Q3 2024 was $2.65M, a 4.03% increase from the previous quarter (Q2 2024), and a 69.83% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.55M, a 47.01% increase from the previous quarter (Q1 2024), and a 125.51% increase year-over-year (Q2 2023). EVOK's quarterly revenue for Q1 2024 was $1.74M, a 3.55% increase from the previous quarter (Q4 2023), and a 114.15% increase year-over-year (Q1 2023).

What is Evoke Pharma’s revenue growth rate?

Evoke Pharma's revenue growth rate for the last 3 years (2021-2023) was 220.17%, and for the last 5 years (2019-2023) was 0%.